Oxlumo® (lumasiran)
| Full Name | Oxlumo® (lumasiran) |
| Drug | Oxlumo |
| Manufacturer | Alnylam Pharmaceuticals |
| Route of Administration | Subcutaneous |
| Site of Care | Home or Healthcare Facility |
| Approved Indication | The treatment of primary hyperoxaluria type 1 (PH1) to lower urinary oxalate levels in pediatric and adult patients |
| Disease | Primary Hyperoxaluria Type 1 (PH1) |
| Therapeutic Area | Nephrology |
| Enrollment Form Link | Oxlumo Enrollment Form |
| Phone Number | 800-460-5217 |
| Fax Number | 877-276-8563 |
| Product Website | oxlumo.com |